Cargando…

Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure

BACKGROUND: Chronic heart failure (CHF) is associated with insulin resistance, indicating impairment in the control of energy metabolism. Insulin resistance in CHF relates to symptomatic status and independently predicts poor prognosis. We sought to determine whether insulin sensitivity is related t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doehner, Wolfram, Turhan, Guelistan, Leyva, Francisco, Rauchhaus, Mathias, Sandek, Anja, Jankowska, Ewa A, von Haehling, Stephan, Anker, Stefan D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410535/ https://www.ncbi.nlm.nih.gov/pubmed/28834658 http://dx.doi.org/10.1002/ehf2.12035

Ejemplares similares

Iron Deficiency and Reduced Muscle Strength in Patients with Acute and Chronic Ischemic Stroke
por: Scherbakov, Nadja, et al.
Publicado: (2022)

Glucose-Induced Hemodynamic and Metabolic Response of Skeletal Muscle in Heart Failure Patients with Reduced vs. Preserved Ejection Fraction—A Pilot Study
por: Boschmann, Michael, et al.
Publicado: (2022)

Non-invasive assessment of cardiac hemodynamics in patients with advanced cancer and with chronic heart failure: a pilot feasibility study
por: von Haehling, Stephan, et al.
Publicado: (2013)

Influence of essential amino acids on muscle mass and muscle strength in patients with cerebral stroke during early rehabilitation: protocol and rationale of a randomized clinical trial (AMINO-Stroke Study)
por: Scherbakov, Nadja, et al.
Publicado: (2016)

Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co‐morbidities Aggravating Heart Failure (SICA‐HF)
por: Saitoh, Masakazu, et al.
Publicado: (2017)

Sleep‐Disordered Breathing in Acute Ischemic Stroke: A Mechanistic Link to Peripheral Endothelial Dysfunction
por: Scherbakov, Nadja, et al.
Publicado: (2017)

Evaluation of C‐terminal Agrin Fragment as a marker of muscle wasting in patients after acute stroke during early rehabilitation
por: Scherbakov, Nadja, et al.
Publicado: (2015)

Highlights from the 7th Cachexia Conference: muscle wasting pathophysiological detection and novel treatment strategies
por: Ebner, Nicole, et al.
Publicado: (2014)

Iron deficiency as energetic insult to skeletal muscle in chronic diseases
por: Dziegala, Magdalena, et al.
Publicado: (2018)

Leukocyte Redistribution: Effects of Beta Blockers in Patients with Chronic Heart Failure
por: von Haehling, Stephan, et al.
Publicado: (2009)

The obesity paradox in chronic disease: facts and numbers
por: Lainscak, Mitja, et al.
Publicado: (2012)

Diabetes mellitus, cachexia and obesity in heart failure: rationale and design of the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)
por: von Haehling, Stephan, et al.
Publicado: (2010)

Higher serum phosphorus is associated with catabolic/anabolic imbalance in heart failure
por: Rozentryt, Piotr, et al.
Publicado: (2015)

Body weight changes and incidence of cachexia after stroke
por: Scherbakov, Nadja, et al.
Publicado: (2019)

Muscle wasting as an independent predictor of survival in patients with chronic heart failure
por: von Haehling, Stephan, et al.
Publicado: (2020)

Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
por: Jankowska, Ewa A., et al.
Publicado: (2013)

Recent developments in the treatment of cachexia: highlights from the 6th Cachexia Conference
por: Ebner, Nicole, et al.
Publicado: (2012)

Iron deficiency is related to low functional outcome in patients at early rehabilitation after acute stroke
por: Doehner, Wolfram, et al.
Publicado: (2022)

IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia
por: Schmidt, Katja, et al.
Publicado: (2011)

Ursodeoxycholic acid treatment in a rat model of cancer cachexia
por: Tschirner, Anika, et al.
Publicado: (2011)

Cachexia in heart disease: highlights from the ESC 2010
por: Kung, Thomas, et al.
Publicado: (2011)

The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats
por: Pötsch, Mareike S., et al.
Publicado: (2013)

Depleted iron stores are associated with inspiratory muscle weakness independently of skeletal muscle mass in men with systolic chronic heart failure
por: Tkaczyszyn, Michał, et al.
Publicado: (2018)

Investigation of changes in body composition, metabolic profile and skeletal muscle functional capacity in ischemic stroke patients: the rationale and design of the Body Size in Stroke Study (BoSSS)
por: Knops, Michael, et al.
Publicado: (2013)

Early rehabilitation after stroke: relationship between the heart rate variability and functional outcome
por: Scherbakov, Nadja, et al.
Publicado: (2020)

Micronutrient Depletion in Heart Failure: Common, Clinically Relevant and Treatable
por: Cvetinovic, Natasa, et al.
Publicado: (2019)

Blocking myostatin: muscle mass equals muscle strength?
por: Anker, Markus S., et al.
Publicado: (2020)

Ferric carboxymaltose for the treatment of iron‐deficient heart failure patients: a systematic review and meta‐analysis
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Single baseline serum creatinine measurements predict mortality in critically ill patients hospitalized for acute heart failure
por: Schefold, Joerg C., et al.
Publicado: (2015)

Identification of Chronic Heart Failure Patients with a High 12-Month Mortality Risk Using Biomarkers Including Plasma C-Terminal Pro-Endothelin-1
por: Jankowska, Ewa A., et al.
Publicado: (2011)

Moving on up: the Journal of Cachexia, Sarcopenia and Muscle
por: von Haehling, Stephan, et al.
Publicado: (2015)

Iron Status and Survival in Diabetic Patients With Coronary Artery Disease
por: Ponikowska, Beata, et al.
Publicado: (2013)

Muscle mass, muscle strength, and functional capacity in patients with heart failure of Chagas disease and other aetiologies
por: da Fonseca, Guilherme Wesley Peixoto, et al.
Publicado: (2020)

MT‐102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia
por: Pötsch, Mareike S., et al.
Publicado: (2020)

Dysfunction of respiratory muscles in critically ill patients on the intensive care unit
por: Berger, David, et al.
Publicado: (2016)

Efforts begin to sprout: publications in JCSM on cachexia, sarcopenia and muscle wasting receive attention
por: Anker, Stefan D., et al.
Publicado: (2014)

More colour to the Journal: new style, new publisher, but still Cachexia, Sarcopenia and Muscle
por: von Haehling, Stephan, et al.
Publicado: (2015)

The Journal of Cachexia, Sarcopenia and Muscle in 2019
por: von Haehling, Stephan, et al.
Publicado: (2019)

Time to jump on the bandwagon: the Journal of Cachexia, Sarcopenia and Muscle in 2018
por: von Haehling, Stephan, et al.
Publicado: (2018)

Growth hormone, insulin-like growth factor 1, and insulin signaling—a pharmacological target in body wasting and cachexia
por: Trobec, Katja, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cqbi5gglo2somn7v7vlupv0rrj